Harmony Biosciences Holdings, Inc. (HRMY)
41.52
+0.42
(+1.02%)
USD |
NASDAQ |
Sep 11, 16:00
41.52
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Price to Book Value : 2.415 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.415 |
| September 10, 2026 | 2.391 |
| September 09, 2026 | 2.421 |
| September 08, 2026 | 2.447 |
| September 04, 2026 | 2.458 |
| September 03, 2026 | 2.435 |
| September 02, 2026 | 2.493 |
| September 01, 2026 | 2.399 |
| August 31, 2026 | 2.290 |
| August 28, 2026 | 2.281 |
| August 27, 2026 | 2.319 |
| August 26, 2026 | 2.307 |
| August 25, 2026 | 2.266 |
| August 24, 2026 | 2.239 |
| August 21, 2026 | 2.219 |
| August 20, 2026 | 2.214 |
| August 19, 2026 | 2.322 |
| August 18, 2026 | 2.258 |
| August 17, 2026 | 2.218 |
| August 14, 2026 | 2.217 |
| August 13, 2026 | 2.239 |
| August 12, 2026 | 2.313 |
| August 11, 2026 | 2.299 |
| August 10, 2026 | 2.268 |
| August 07, 2026 | 2.234 |
| Date | Value |
|---|---|
| August 06, 2026 | 2.254 |
| August 05, 2026 | 2.224 |
| August 04, 2026 | 2.256 |
| August 03, 2026 | 2.071 |
| July 31, 2026 | 2.050 |
| July 30, 2026 | 2.086 |
| July 29, 2026 | 2.086 |
| July 28, 2026 | 2.081 |
| July 27, 2026 | 2.094 |
| July 24, 2026 | 2.054 |
| July 23, 2026 | 2.082 |
| July 22, 2026 | 2.028 |
| July 21, 2026 | 2.143 |
| July 20, 2026 | 1.948 |
| July 17, 2026 | 1.964 |
| July 16, 2026 | 1.950 |
| July 15, 2026 | 2.030 |
| July 14, 2026 | 2.025 |
| July 13, 2026 | 2.067 |
| July 10, 2026 | 2.143 |
| July 09, 2026 | 2.222 |
| July 08, 2026 | 2.215 |
| July 07, 2026 | 2.225 |
| July 06, 2026 | 2.153 |
| July 02, 2026 | 2.167 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Liquidia Corp. | 30.48 |
| Repligen Corp. | 4.413 |
| Johnson & Johnson | 7.527 |
| Pfizer Inc. | 1.854 |
| Bristol Myers Squibb Co. | 5.825 |
Price to Book Value Related Metrics
| PE Ratio | 13.45 |
| PS Ratio | 2.541 |
| Price to Free Cash Flow | 7.266 |
| Price | 41.52 |
| Earnings Yield | 7.43% |
| Market Cap | 2.413B |
| Operating PE Ratio | 10.57 |
| Normalized PE Ratio | 13.45 |